Genomic and supragenomic structure of the nucleotide-like G-protein-coupled receptor GPR34  by Engemaier, Eva et al.
sevier.com/locate/ygenoGenomics 87 (200Genomic and supragenomic structure of the nucleotide-like
G-protein-coupled receptor GPR34i
Eva Engemaier, Holger Ro¨mpler, Torsten Scho¨neberg, Angela Schulz *
Institute of Biochemistry, Department of Molecular Biochemistry, Medical Faculty, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany
Received 8 July 2005; accepted 7 October 2005
Available online 9 December 2005Abstract
Directed cloning approaches and large-scale sequencing of several vertebrate genomes unveiled many new members of the G-protein-coupled
receptor (GPCR) superfamily, among them GPR34. Initial studies showed that GPR34 is an evolutionarily old GPCR structurally related to a
group of ADP-like receptors. To gain insight into the genomic organization, regulation of expression, and supragenomic diversification of GPR34
several vertebrate species were analyzed. In contrast to the obviously intronless coding region GPR34 displays an evolutionary preserved 5V
noncoding intron–exon structure. Further, an alternatively used cryptic intron was identified within the coding region, which shortens the N
terminus by 47 amino acids. Ubiquitous expression of GPR34 is driven by genomic sequences upstream of at least two transcriptional start regions
in mouse and rat but only one region in human. In rodents, both promoters are active in all tissues investigated, but the level of activity is tissue-
specific. At the translational level, several conserved in-frame AUGs within the first 150 bp of the coding region may serve as start points for
translation in human and other mammals. Combinatory mutagenesis and expression of reporter constructs confirmed these multiple translational
start points and revealed a preference for the second in-frame AUG in human GPR34. Our data show that multiple translation initiation starts and
alternative splicing contribute to the supragenomic diversification of GPR34.
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sequencing projects revealed more than 1000 genes belonging
to the G-protein-coupled receptor (GPCR) superfamily. Two-
thirds of these genes are thought to encode odorant receptors.
Of the remaining third, the natural ligand for only half of the
receptors has been identified, leaving about 160 so-called
‘‘orphan’’ GPCRs with unknown agonists [1]. Once the
sequence of a GPCR is known, understanding the function of
the encoded protein becomes a task of paramount importance.
Consequently, pharmacological characterization and functional
genomic strategies can be employed to identify activating
ligands and their functional relevance.0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2005.10.001
Abbreviations: GPCR, G-protein-coupled receptor; hGPR34, human
GPR34; mGPR34, mouse GPR34; ORF, open reading frame; ROX, carboxy-
X-rhodamine; UTR, untranslated region; RT-PCR, reverse transcription PCR.
i Sequence data from this article have been deposited with the GenBank Data
Library under Accession Nos. DQ_106398–DQ_106402 (human ESTs),
DQ_103764–DQ_103767 (mouse ESTs), and DQ_106403 (bonobo GPR34).
* Corresponding author. Fax: +49 341 9722159.
E-mail address: angela.schulz@medizin.uni-leipzig.de (A. Schulz).In initial studies we and others showed that GPR34 has clear
structural and functional features of the group of ADP-like
GPCRs [2–5]. This group includes the ADP receptors P2Y12
and P2Y13, the UDP-glucose receptor (GPR105), and the orphan
GPCRs GPR87 and GPR34. In mammals GPR34 is located on
the X chromosome, making this receptor an interesting can-
didate gene for human diseases linked to the Xp11.4 locus [6,7].
The presence of GPR34 in cartilaginous and ray-finned fish
genomes suggests that the evolution of this receptor likely
started in the Cambrian period more than 450 million years ago
[3]. While mammalian GPR34 orthologs are single-copy genes
encoded by an obviously intronless coding region, a greater
GPR34 diversity is found in teleost fishes. Here, two GPR34
genes are observed in many fish species, probably a conse-
quence of genome duplication in early teleost fish evolution [8].
Later, a single intron was introduced into the coding region of
only one GPR34 gene. Subsequent gene duplication in some
teleost fish species furthered GPR34 diversification [3].
Present knowledge of GPR34 structure is based only on
genomic analysis of the coding region in vertebrates. However,6) 254 – 264
www.el
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supragenomic processes such as splicing and mRNA editing and
at the translational level. Therefore, we set out to address these
questions from an evolutionary perspective by analyzing allelic
variability in the human population, genomic organization,
expression regulation, and supragenomic diversification of this
orphan GPCR. We found that GPR34 genes have a highly
conserved exon–intron structure in mammals that gives rise to
splice variants also affecting the GPR34 coding region. Receptor
diversification is probably further increased by the presence of
multiple translation initiation sites.
Results and discussion
Low allelic diversity of the GPR34 coding region within the
human population
The occurrence of different allelic variants can contribute to
GPCR structural and functional diversity. Because GPR34 is an
X-chromosomal gene, mutations can become relevant even at
low frequency in the population. To search for frequent GPR34
alleles we first analyzed the coding region of 20 randomly
chosen human individuals of Caucasian origin. Interestingly, we
identified a male hemizygous for a silent GTA to GTG exchange
at codon position 296. Analysis of his mother revealed
heterozygosity at this position. This initial screen prompted us
to extend the analysis. Since genetic diversity is best related to
linguistic groups [9], we sequenced the GPR34 coding region in
85 humans representing all major linguistic groups [9].
However, no sequence variations within the GPR34 coding
region were found in this worldwide panel. Further, database
mining (SNP database at NCBI; http://www.hapmap.org)
revealed no frequent single nucleotide polymorphisms (SNP)
yet identified. Very recently, Iida and Nakamura [10] searched
for SNPs in 29 GPCRs, including GPR34, in 48 healthy
Japanese individuals and found no frequent SNP in the coding
region. This does not exclude individual variations as found in
our Caucasian sample set (see above); our observations support
the finding that there are no frequent or fixed allelic variants in
major human subpopulations.
The chimpanzee (NM_001009135) and pygmy chimpanzee
(bonobo; DQ_106403) GPR34 sequences differ from their
human ortholog at only two silent nucleotide positions. Because
chimpanzees showed a significantly higher interindividual
sequence diversity compared to humans [11,12], we analyzed
the GPR34 coding sequence of 10 chimpanzee individuals.
Again, no interindividual sequence differences were found in
chimpanzee, indicating that the GPR34 sequence remained
highly conserved over the past 5.5 Myr of hominoid speciation.
These data support the conclusion that, in contrast to other
GPCRs [13], allelic variants do not contribute to the structural
diversity of GPR34.
GPR34 has a conserved 5V-exon–intron structure
At the time this study was initiated there was only limited
information (EST database) suggesting an exon–intron struc-ture within the 5V UTR of GPR34. To validate these first hints
and to search for heterogeneity of GPR34 transcripts due to
alternative splicing or mRNA editing we compared mRNA and
genomic sequences of GPR34.
Fifty-two transcripts from human fetal brain and human
promyeloic cell line HL60 cDNA libraries, 36 transcripts of
mouse fetal and brain cDNA libraries, and 3 transcripts of a
rat spleen cDNA library were analyzed and compared with
genomic sequences taken from the database (GenBank
Accession Nos. AL627402 (human), AL671117 (mouse),
AABR03119244 (rat)). First, we found no evidence of mRNA
editing in any of the GPR34 transcripts. Second, in contrast to
the discernibly intronless coding sequence, we found an exon–
intron structure 5V of the GPR34 coding region (Fig. 1, Table
1). Comparison of the exon–intron structure between human,
mouse, and rat genes implicated a homologous transcription
start region approximately 6.5 kb upstream of the translation
start site. The first two exons are present in all observed human,
mouse, and rat GPR34 transcripts (Fig. 1A). In some human
and mouse transcripts one or two additional exons were found
and could be traced to a genomic sequence positioned between
exon 2 and the coding region (see Fig. 1A, rare exons, Table 1).
It is of interest to note that the splice acceptor site of human
exon 3 is variable. Most commonly used is the acceptor site
79. In several transcripts exon 2 was linked to the 6 splice
site (see Fig. 1A, human) but an in-frame stop codon in exon 2
avoids 5V extension of the open reading frame. We also
characterized the 3V UTR of human, mouse, and rat GPR34 but
found no indications of introns in this region. Most cDNA 5V
ends were found in an ¨90-bp region upstream of the splice
donor site in exon 1 (Figs. 1A and 1B). The high degree of
conservation between human and rodent cDNA 5V ends as well
as the presence of conserved TATAA and CCAAT boxes in
close proximity to this genomic segment are all indicative of a
transcriptional start site (further referred to as proximal
promoter). Surprisingly, we found several transcripts in the
mouse and rat cDNA libraries with a different transcription
start point located approximately 700 bp upstream of the main
transcriptional start site (Fig. 1, mouse, rat, distal promoter).
Here, the region of the main transcriptional start becomes part
of an exon (exon 1). All attempts to identify human transcripts
that use this distal promoter failed so far. Our data are in good
agreement with previous Northern blot studies that identified
two main transcripts (2.1 and 2.3 kb) in mouse and rat tissues
but not in human samples [2,4]. The sizes of the rodent
transcripts we identified by sequencing nicely match with the
band sizes found in Northern analysis and it is, therefore, very
likely that the 2.1- and 2.3-kb bands represent the products of
the proximal and distal promoter, respectively.
By analyzing PCR fragments that had significant differences
in length compared to the most frequent transcripts we identified
a splice variant of GPR34 lacking 70 bp within the N-terminal
coding region. This splicing is due to a cryptic intron within the
coding region (see Fig. 1A, human). The splice sites of the
cryptic intron in human GPR34 transcripts are also present in the
mouse sequence. To date, we have not found a murine GpR34
transcript in which this cryptic intron is indeed used.
E. Engemaier et al. / Genomics 87 (2006) 254–264256As shown recently, GPR34 is evolutionarily old, being
present in all vertebrate classes [3]. Identification of over 60
vertebrate GPR34 orthologs enabled us to analyze the genomicstructure in other mammalian and nonmammalian species. As
found in rodents and human, other mammalian GPR34 genes
(dog, cow, pig), as well as nonmammalian chicken, Xenopu-
Table 1
Summary of GPR34 mRNA specimens found in mouse and human
Accession
No.
Species Structure of GPR34 mRNA Transcript frequency
(of all sequenced transcripts)
Transcript frequency
(found in EST database)
DQ 106398 Human Exon 1, exon 2 52/56 56/59
DQ 106399 Human Exon 1, exon 2, rare exon (–5243/–5145) 1/56 —
DQ 106400 Human Exon 1, exon 2, rare exon (–3026/–2897) 1/56 1/59
DQ 106401 Human Exon 1, exon 2, spliced to position –6 instead of –79 1/56 2/59
DQ 106402 Human Exon 1, exon 2, cryptic intron (+45/+115) 1/56 —
DQ 103764 Mouse Exon long, exon 1, exon 2 1/36 3/6
DQ 103765 Mouse Exon long, exon 1, exon 2, rare exon 1/36 —
DQ 103766 Mouse Exon 1, exon 2 26/36 3/6
DQ 103767 Mouse Exon 1, exon 2, rare exon 8/36 —
Transcripts from human fetal brain and human promyeloic cell line HL60 cDNA libraries and from mouse fetal and brain cDNA libraries were cloned and
sequenced. Accession numbers of different sequences and exon presence in the transcript and their frequency in our sample set and the EST database are given.
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the first in-frame AUG. This indicates that the promoter region
was already separated from the GPR34 coding region by an
intron very early in vertebrate evolution and that this 5V-intron–
exon-structure was maintained in all vertebrate classes yet
sequenced.
GPR34 is ubiquitously expressed
Characterization of the GPR34 gene structure revealed a
complex exon–intron structure and at least two putative
transcription initiation sites that prompted us to analyze
GPR34 expression and expression regulation. Initial Northern
blot analysis suggested ubiquitous GPR34 expression in all
embryonic and adult tissues investigated [2]. To verify and
extend these analyses, PCRwas performed using multiple-tissue
cDNA libraries from human, mouse, and rat. As shown in Fig.
2A, GPR34 transcripts are expressed in all human and mouse
tissues. Further, GPR34 transcripts are also found in HL60 cells
and the murine macrophage cell line RAW 264.7 (data not
shown).
We next employed rat multiple tissue cDNAs to search for
tissue-specific promoter usage. PCR detection of transcripts
from both promoters required two setups with different sense
primers (Fig. 2B). In the first step, to detect transcripts yielded
from the distal promoter, a sense primer was chosen to anneal to
the most distant exon (exon long). PCR fragments from this
approach contained parts of the most distant exon, exons 1 and 2,
and a part of exon 3. The second setup used a sense primer that
annealed in exon 1, thereby yielding shorter PCR products than
in the previous setup. In all tissues investigated both PCR
strategies produced specific fragments, indicating that probably
both promoters are active in rodents independent of tissue type
(see Materials and methods; data not shown). Finally, we askedFig. 1. GPR34 genomic organization and transcription start determination. (A) To de
were analyzed and compared with NCBI database genomic sequences. Exons 1 and
coding region (black) and splice sites are shown for each exon with numbering refer
the second intron region were found in only some of the human and mouse transc
coding region of hGPR34. A second transcriptional start site, upstream of the firs
promoter region (distal promoter) contained the first transcriptional start as an exon
transcriptional start is located about 6.5 kb upstream of the coding region. Aligned h
start are shown. These sequences contain conserved TATAA and CCAAT boxes. T
circles: gray, mouse; dark gray, human).whether promoter usage differs in distinct parts of a chosen
organ. Thus, analyses were performed with cDNAs of different
heart regions (left and right atrium, ventricle, aortal part) and, as
with whole organ, we observed specific fragments for both
primer setups (see Fig. 2B).
In order to quantify and verify the activity of both promoters
in mice real-time PCR assays were performed for different
tissues. As in case of rat Gpr34, parts of the proximal promoter
and its transcription start are an integral part of transcripts of
the distal promoter (see Fig. 1 and Table 1). Ct values of
transcripts of the distal promoter were determined directly from
primer pair 1-derived PCR product. Because parts of the
proximal promoter and its transcription start are an integral part
of transcripts of the distal promoter (see Fig. 1 and Table 1),
primer pair 2 amplifies transcripts yielded from both promoters
(represents the total Gpr34 transcript number). Therefore, Ct
values originating from only the proximal promoter had to be
determined indirectly by subtraction of the copy number
yielded from primer pair 1 from the copy number yielded
from primer pair 2. To ensure equal amplification efficiency of
both Gpr34 primer pairs standard curves were generated using
serial dilutions of cloned Gpr34 cDNA. As shown in Fig. 3, Ct
values for primer pair 1 and primer pair 2 were identical for all
mGpr34 cDNA concentrations.
The highest levels of Gpr34 transcripts were found in brain
and spleen (Table 2). As found for rat, transcripts from both
promoters were found in all murine tissues investigated.
Interestingly, activity of the distal promoter was¨14-fold lower
in liver compared with the proximal promoter activity in the
same tissue (Table 2). In contrast, distal promoter activity was
more prominent in heart and spleen. Latter data are in good
agreement with Northern blot data showing a more intensive
2.3-kb band, which most likely represents transcripts of the
distal promoter (see above).termine the gene structure of GPR34 in human, mouse, and rat, specific mRNAs
2 (ex1, ex2) are present in all transcripts from the three species (red line). The
ring to the first putative translation start codon. Additional exons located within
ripts. Further, a cryptic intron was identified (gray box) within the N-terminal
t, was identified in rodent Gpr34 genes. Transcripts derived from this second
, termed ‘‘exon long’’. (B) In the majority of human and rodent transcripts, the
uman and rodent sequences upstream of this most frequently used transcription
he number and position of the 5V end of the transcripts are given (encoded by
Fig. 2. Ubiquitous expression of GPR34 in different species. The expression pattern of GPR34 was determined by reverse transcriptase PCR. Thus, GPR34-specific
primer pairs, located in exon 1 and exon 3 (Fig. 1), and mouse and human cDNA panels were used (see Materials and methods) and (A) PCR results are shown. For
cDNA quality control purposes GPDH expression was monitored in parallel. (B) cDNAwas prepared from different regions of the rat heart and two sets of primers,
located in exon long and exon 3 (left) or in exon 1 and exon 3 (right), were used to monitor the usage of both promoters.
Fig. 3. Real-time PCR standard curves for Gpr34. Real-time PCR was used to
quantitate the activity of both Gpr34 promoters in mouse tissue. Primer pair 1
was specific to transcript from the distal promoter. Primer pair 2 amplifies
transcripts from both the proximal and the distal promoter because al
transcripts of the distal promoter also contained parts of the proximal promote
and its transcription start (see Fig. 1 and Table 1). Therefore, proximal promote
activity can be determined only indirectly by subtraction of the copy numbe
yielded from primer pair 1 from the copy number yielded from primer pair 2
(for equation see Table 2). To ensure equal amplification efficiency of both
Gpr34 primer pairs standard curves were generated using serial dilutions o
cloned Gpr34 cDNA (Accession No. DQ 103764, see Table 1) containing 20
80, 320, 1280, 5120, and 20,480 copies per 3 Al.
E. Engemaier et al. / Genomics 87 (2006) 254–264258Taken together, our data show that the ubiquitous expression
of GPR34 is mediated by at least one promoter in human and
two promoters in rodents. As found in mouse there is evidence
for tissue-specific preference of one of the two promoter
regions, at least in liver.
Promoter studies of GPR34
The ubiquitous expression of GPR34 suggests constitutive
and cell-type-independent promoter function. To probe pro-
moter activity further, three mouse genomic fragments,
including the conserved transcriptional start; the CCAAT
and TATAA boxes; and 0.5, 1.5, and 2 kb of upstream
sequences; were cloned into the promoterless pcDNAI/Amp
vector (Fig. 4). The firefly luciferase gene was used as
reporter. To ensure equivalent mRNA stability and translation,
we preserved the sequence environment by cloning the entire
mouse Gpr34 5V UTR between the putative promoter
sequences and the ATG of luciferase (see Fig. 4). The
CMV promoter in the Gpr34 5V UTR context served as a
positive control, while constructs without a promoter sequence
served as negative controls. COS-7 and RAW cells were
transfected with these constructs and luciferase activity was
measured. The lower absolute luminescence in RAW cells
was due to the significantly lower transfection efficiency in
this cell line (0.1% in RAW compared to 43% in COS-7 cells
as determined by transfection of GFP-encoding plasmid and
counting of fluorescent cells). None of the genomic fragmentsl
r
r
r
f
,
Table 2
Quantification of transcripts from proximal and distal mouse Gpr34 promoter
Tissue Mouse Gpr34 mRNA Controls
DC t
a (distal promoter) DCt
a (proximal promoter) Ratio promoter activityb (proximal/distal) h2-Microglobulin (C t value) Clathrin (Ct value)
Brain 8.56 T 0.18 8.48 T 0.39 1.07 T 0.18 16.5 T 1.05 16.9 T 0.74
Liver 15.70 T 0.42 11.97 T 1.00 14.37 T 5.53** 14.7 T 0.64 17.7 T 0.74
Heart 10.76 T 0.6 11.37 T 0.34 0.67 T 0.17* 16.4 T 0.88 18.6 T 0.92
Spleen 8.39 T 0.16 9.08 T 0.56 0.65 T 0.20* 15.3 T 1.03 19.0 T 1.39
Skeletal muscle 11.23 T 0.93 10.70 T 0.51 1.60 T 0.75 17.3 T 1.69 19.4 T 1.90
Kidney 12.08 T 0.30 12.48 T 0.62 0.88 T 0.36 15.9 T 0.86 17.3 T 1.17
Three micrograms of total RNA from different tissues was subjected to reverse transcriptase reaction. Quantitative real-time PCR (TaqMan assay) was performed for
each transcript and controls (h2-microglobulin, clathrin) as described under Materials and methods.
a Ct values were normalized to the C t values of the controls and are given as DCt (DC t = Ct – (Cth2-microglobulin + Ctclathrin)/2).
b The ratio was determined using the equation 2(DC t distal –DC t proximal). Data are presented as means T SD of four independent experiments (four individual mice)
each performed in duplicate. Significant differences between C t values of proximal and distal promoter transcripts from the same tissue are marked.
* p = 0.05.
** p < 0.01.
E. Engemaier et al. / Genomics 87 (2006) 254–264 259of the putative Gpr34 promoter region showed significant
activity in either cell line compared to the expression of
promoterless constructs (Table 3).
It is well known that promoter activity can be influenced by
downstream intron and genomic sequences [14–19]. There-
fore, the intron sequence between exons 1 and 2 (intron 1) was
inserted in its genomic context into the original reporter
constructs (see Fig. 4, referred to as 0.5-Int, 1.5-Int, and 2.0-
Int) and expressed in both cell lines. Again, CMV control
vector-transfected cells showed high luciferase activity; how-
ever, no specific promoter activity was found for the putative
Gpr34 promoter constructs. Proper intron splicing was con-Fig. 4. Promoter constructs. To test for potential promoter activity, 0.5, 1.5, and 2.0
were cloned into two firefly luciferase-based reporter constructs (see Materials and
SV40 promoters in pcDNAI/Amp and pGL3 vector, respectively. Additional constru
UTR (see also Table 1).firmed by sequencing of specific PCR fragments from cDNA
of RAW cells transfected with the CMV-Int control vector. It is
of interest to note that introduction of the intron significantly
increased basal and CMV promoter-driven luciferase activity,
probably a consequence of higher mRNA stability, mRNA
abundance, or some additional promoter activity of the intron
sequence.
To exclude the possibility that the lack of Gpr34 promoter
activity was due to context effects caused by the pcDNAI/Amp
vector backbone, all intron-containing Gpr34 promoter con-
structs were subcloned into the pGL3 vector. Here, an SV40
promoter served as positive control. As observed in thekb of mouse genomic sequence upstream of the major transcriptional start site
methods). As a positive control, luciferase expression was driven by CMV and
cts were generated by cloning intron 1 into the appropriate position within the 5V
Table 3
Luciferase activity of different promoter constructs in two vector systems
Construct Promoter Luciferase activity (COS-7 cells) (fold over control) Luciferase activity (RAW264.7 cells) (fold over control)
pcDNAI/Amp pGL3 pcDNAI/Amp pGL3
CMV CMV 55,950 T 6360 – 42.9 T 2.0 –
No-Pro None 593 T 197 – 6.4 T 0.2 –
0.5 Gpr34 79 T 19 – 1.7 T 0.5 –
1.5 Gpr34 107 T 30 – 2.4 T 0.3 –
2.0 Gpr34 139 T 33 – 3.9 T 0.3 –
CMV/SV40-Int CMV/SV40 541,131 T 105,894 834,564 T 273,855 634 T 166.4 63.5 T 17.5
No-Pro-Int None 4990 T 740 888 T 297 9.3 T 0.9 5.6 T 1.6
0.5-Int Gpr34 8308 T 2022 563 T 173 8.6 T 1.8 6.1 T 1.4
1.5-Int Gpr34 1653 T 617 345 T 120 6.8 T 1.2 2.9 T 0.5
2.0-Int Gpr34 1685 T 584 117 T 38 6.5 T 1.6 2.6 T 0.6
For testing the promoter activity of the genomic sequence 5Vof the transcription start, different 5V regions of Gpr34 were cloned upstream of the firefly luciferase coding
sequence inserted into pcDNAI/Amp and pGL3 vectors as described under Materials and methods. Luciferase activity in COS-7 cells was measured and is presented as
fold over negative control (GFP-transfected cells, 24.5 T 8.6 cps/pcDNAI/Amp; 60 T 20 cps/pGL3). Results are given as means T SEM of four (pcDNAI/Amp
constructs) or three (pGL3 constructs) independent experiments performed in quadruplicate. For RAW264.7 cells results for three representative experiments are shown
and given as means T SEMof three (pcDNAI/Amp and pGL3 constructs) independent experiments performed in quadruplicate. Background activity of GFP-transfected
cells (negative control) was 27.3 T 6.1 cps for pcDNAI/Amp and pGL3. cps, counts per second.
E. Engemaier et al. / Genomics 87 (2006) 254–264260pcDNAI/Amp vectors, no specific activity of the putative
Gpr34 promoter regions was found in the pGL3 vector
constructs.
Finally, we generated a construct containing the Gpr34
coding sequence and 6.7 kb of genomic sequence upstream of
the Gpr34 start AUG (0.7 kb putative promoter sequence plus
all exons and introns). This minigene construct was transfected
into COS-7 cells and expression was monitored by reverse
transcribing the mRNA into cDNA followed by PCR and
sequencing of PCR products. PCR fragment analysis revealed
properly spliced mGPR34 mRNA, indicating that the GPR34
minigene shows promoter activity. However, the high sensi-
tivity of this PCR-based approach was not comparable directly
to the results from luciferase reporter assays. Therefore, RT-
PCR analysis was repeated for mRNA of 0.5-Int-transfected
COS-7 and RAW cells using 5V UTR sense and luciferase-
specific antisense primers. As for the minigene-transfected
cells, properly spliced cDNA was identified, suggesting some
Gpr34 promoter activity. Because these transcripts do not
significantly contribute to luciferase activity above control
transfected cells (Table 3) we interpret this observation as a
leaky transcriptional activity rather than specific promoter-
driven expression.
In sum, despite clear identification of the transcriptional start
in the rodent and human GPR34 genes, analysis of the upstream
sequence provided no clear indications of promoter activity in
vitro and, therefore, awaits further studies, e.g., analysis of larger
upstream sequences in the context of the used minigene.
Translation of GPR34 is ensured by several in-frame AUG
codons
Translation of mRNA into protein usually starts at the first
AUG within the open reading frame (ORF). A scanning
mechanism for AUG and distinct sequence patterns that ensure
the recognition of this translational start point by the ribosomal
machinery has been identified [20]. The scanning mechanism
suggests that ribosomes traverse the 5VUTR and that translationof the major coding domain is reduced when out-of-frame AUG
codons occur upstream. Our mRNA analysis revealed that
human and murine GPR34 mRNAs usually contain two to six
and two to three AUGs, respectively, which are upstream of the
first in-frame AUG. The number of upstream AUGs depends on
mRNA splicing, and the resulting ORFs are fewer than 22
codons long. If an upstream AUG is used by the ribosomal
machinery, then translation of the main ORF requires either
reinitiation of translation or a context-dependent leaky scanning
[20]. Further, a growing number of studies show that translation
start for transcripts with multiple AUG can occur not only at the
first AUG within the ORF [21,22]. The presence of several
AUGs in the 5VUTR and up to five AUG codons within the first
150 bp of the putative N terminus of mammalian GPR34 (Fig.
5A) raised the question of which of the in-frame AUG codons
serves as a translational start point. For example, the second in-
frame AUG (Met8) in human GPR34 is the first AUG in mouse
and rat GPR34 mRNA; thus, we want to determine which in-
frame AUG is used in human GPR34. To address this question,
the first three in-frame AUG codons were combinatorially
mutated to TTG in a hGPR34–GFP fusion construct. As shown
in Fig. 5B, all three AUG can initiate robust translation. A
significant reduction in GFP fluorescence (55 T 14.0% of the
wild-type construct A1111) was observed when all three AUGs
were eliminated (A0001). Similarly, the open reading frame of
the hGPR34 splice variant (cryptic intron, see above) lacking 47
amino acids of the N terminus also started with AUG4 and it
showed 75 T 10.4% of the fluorescence of the wildtype
construct A1111. This observation is of interest because the
transcript of the splice variant still contains the first two AUGs
(codons 1 and 8), albeit out of frame. To demonstrate proper
hGPR34 expression and localization in the plasma membrane,
confocal immunofluorescence studies were performed. All
hGPR34–GFP constructs were found in the plasma membrane
(data not shown), indicating proper receptor folding and
trafficking.
To verify these results and to exclude the possible contribu-
tion of translational start from a more downstream AUG, GFP
Fig. 5. Translation start analysis in Gpr34. (A) N-termini sequence comparison of different GPR34 orthologs shows multiple in-frame AUGs in Gpr34 and other
mammalian GPR34 sequences. (B) To identify the translation initiation codon(s) a combinatory mutagenesis strategy was applied to the first three in-frame AUG
codons (AUG to UUG mutation). Translation was monitored by quantification of fluorescence emitted by the various GPR34–GFP fusion constructs (see also C
and D). Results are presented as percentage of the corresponding wild-type construct. (C) In a second set of constructs GFP was fused directly to the N terminus
of hGPR34. Constructs depicted in panel D contain only the first third of the N-terminal coding region, which was fused to GFP. The putative translation sites at
codon positions 1 and 8 were subsequently mutated. Data in the tables are given as means T SEM of three independent experiments, each performed in
quadruplicate. n.d.—not determined.
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Translationwas found for all constructs; however, deletion of the
transmembrane coding region left the fusion proteins soluble
within the cells as analyzed by confocal microscopy (data not
shown). Strikingly, mutation of the second and third AUGs
(B1001) resulted in a significant reduction in translation,
indicating that AUG2 and AUG3 contribute to maximal
translation.
Finally, constructs containing only the first two potential
translation AUGs were tested. As shown in Fig. 5D, either
AUG was capable of translation initiation, whereas mutation of
both AUG codons resulted in a loss of expression. As found in
B constructs, the second AUG significantly contributes to
translation and appears to be most efficiently used, although the
context (3 to 1 and +4 position) of both AUGs is identical
in the human sequence. GPR34 may therefore represent a new
example that demonstrates escape from the first-AUG rule
[20].
Our experiments showed that translation can occur from all
four in-frame AUG codons within the human GPR34 N
terminus when each of these AUGs is set first in the ORF. It is
well established that both the AUG and its sequence context
determine the efficacy of translation start initiation [20]. One
may argue that AUG codon usage by the translation apparatuslacks specificity in our heterologous expression system since
each AUG is used to some extent, but cells transfected with a
construct bearing an endogenous out-of-frame AUG brought
in-frame to GFP (AUGfs) showed no fluorescence above
control (GFP without AUG) (Figs. 5A and 5D). These findings
confirm the specificity of expression driven by endogenous in-
frame AUG codons.
Taken together, the 5V UTR and the ORF of several
mammalian GPR34 contain more than one potential translation
start AUG and, at least in hGPR34, there is evidence of
alternative usage, most likely through a leaky-scanning mech-
anism. Multiple AUG codons at the very beginning of the ORF
in close proximity may have an advantage to ensure and
maximize translation. Furthermore, this gene structure guaran-
tees translation even if one AUG got lost by mutation or during
evolution. The multiple translation starts may also contribute to
supragenomic diversity in receptor length. This is supported by
previousWestern blot studies of hGPR34 [24]. Here, the specific
immunostaining indicates reasonable molecular weight diversi-
ty, and receptor length differences may contribute to these
findings. One can speculate that different ‘‘receptor isoforms’’
may have different functions as shown for other proteins [23,25].
Unless the natural agonist is identified this question remains to
be addressed.
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GPR34 displays remarkably low allelic diversity over the
past 5 Myr of hominoid evolution and allelic variants are rare
in the human population. The 5V UTR of GPR34 transcripts is
derived from a conserved intron–exon structure upstream of
the coding region. Despite aberrant splicing of cryptic introns
within both this region and the N-terminal coding region, the
gene structure does not contribute significantly to generating
isoforms of this single-copy gene. However, several AUG
codons in the 5V UTR and at the very beginning of the main
ORF suggest alternative initiation of translation. Indeed,
several lines of experimental evidence implicate a remarkable
leaky scanning of GPR34 mRNA for start AUG codons, which
may provide the basis of length isoforms of GPR34.
Materials and methods
Genomic sequence analysis of the human GPR34
To identify individual variations we sequenced the GPR34 coding region in
105 humans (85 individuals of the DNA panel as described previously [9] and 20
German individuals). PCR fragments were amplified with genomic DNA
samples and the primer pair 5V-CACTTTTTGATCTCCACAGAAGACA-3V/5V-
GTTCTTCAAAGAATTAAGAGGCTGC-3V. Genomic DNA (100 ng) was used
in PCRs (50 Al) with primers (20 pmol each), standard buffer (Perkin–Elmer
Applied Biosystems, Foster City, CA, USA), dNTP (200 AM), and Taq
polymerase (1 U; Perkin –Elmer). The reactions were initiated with a
denaturation at 94-C for 3 min, followed by 35 cycles of denaturation at 94-C
for 45 s, annealing at 60-C for 45 s, and elongation at 72-C for 2 min. A final
extension step was performed at 72-C for 10 min. PCR products were separated
in a 1.5% agarose gel, purified using a PCR Product Purification Kit (Qiagen),
and sequenced.
Generation of cDNA libraries from different tissues and cell lines
Large-scale GPR34 mRNA analysis via rapid amplification of cDNA ends
(RACE) of human, mouse, and rat tissue was utilized for comparative analysis of
the genomic structure and identification of editing events, splice variants, and
transcription start sites. cDNA was generated from total RNA from the human
promyeloic cell line HL60 (which expresses GPR34) and rat spleen using
Fenozol according to the manufacturer’s protocol (Active Motif; Rixensart,
Belgium). Total RNAwas transcribed into cDNA libraries using the GeneRacer
Kit (Invitrogen, Karlsruhe, Germany). The amplification of GPR34 cDNAs was
performed using specific antisense primers (human, 5V-AAATACATA-
GAGGGCGATTATGTTCCCAACCAG-3V; mouse and rat, 5V-CAGAAATA-
CATAGAGGGCAATGATGTTTCCAACCA-3V) and RACE primers provided
with the kit. Additionally, RACE analysis was performed with the human fetal
brain Marathon-Ready cDNA library according to the manufacturer’s protocol
(BD Biosciences, Palo Alto, CA, USA). For analysis of mouse Gpr34 transcripts
we used a brain and fetal mouse Marathon-Ready cDNA library from leukocytes
(BD Biosciences) with the gene-specific antisense primer 5V-CAGAAATACA-
TAGAGGGCAATGATGTTTCCAACCA-3Vand the cDNA library linker primer
AP1.
PCR products from all libraries were cloned into the pCR2.1-TOPO
vector (Invitrogen) and sequenced with Thermosequenase and dye-labeled
terminator chemistry by an automated sequencer (Applied Biosystems,
Foster City, CA, USA).
Expression pattern analysis of GPR34
For sensitive characterization of GPR34 expression in mouse and human
tissues, PCR analyses were performed using cDNA mouse panel I and human
panels I and II (BD Biosciences). To exclude amplification of genomiccontaminations within cDNA libraries primers were complementary to GPR34
exon sequences that flank introns in the genomic sequence. For mouse PCR the
primer pair 5V-TTGGGTTTACTCCTTTTACTTCAGG-3V/5V-CAGAAATACA-
TAGAGGGCAATGATGTTTCCAACCA-3V and for human cDNA the primer
pair 5V-GGTTCTGCTCCTTTTACTTCAGGCG-3V/5V-AAATACATAGAGGG-
CGATTATGTTCCCAACCAG-3Vwere used. As control GPDH fragments were
amplified with primers provided by the manufacturer (BD Biosciences).
For expression analysis in rat, tissues were dissected (brain, heart, aorta,
spleen, skeletal muscle, esophagus, stomach, small intestine, appendix,
rectum, liver, bladder, kidney, suprarenal gland, testes, epididymides) and
total RNA was prepared as described above. Reverse transcription was
performed using a mixture of oligo(dT) primer and random hexamers. The
resulting cDNAs were used in PCRs with the following primer sets:
5V-TTTTCCTTGAAATAGGAGAGAGCAC-3V/5V-CAGAAATACATAGA-
GGGCAATGATGTTTCCAACCA-3V (transcript exon long) and 5V-TTGGGTT-
TCCTCCTTTACTTCAGC-3V/5V-CAGAAATACATAGAGGGCAATGAT-
GTTTCCAACCA-3V (transcript exon 1/2, Fig. 2B).
Real-time PCR assay
Total RNA was isolated from approximately 20 mg of tissues using Trizol
(Invitrogen) according to the manufacturer’s protocol. Complementary DNA
was synthesized from 3 Ag of total RNAwith reverse transcriptase (Superscript
II kit; Invitrogen) and an oligo(dT) primer. Quantification of gene expression
was performed by real-time PCR (ABI Prism 7700 sequence detection system
(Perkin–Elmer)) and SybrGreen (Invitrogen) according to the manufacturer’s
protocol. For each reaction 25 Al of SybrGreen mix, 3 Al of cDNA template
solution, 2  1.5 Al of primer (10 AM), 1 Al of ROX, and 18 Al of H2O were
used. To quantify murine GPR34 transcripts two primer pairs were used: pair 1,
5V-GCCTCAGCATCTTTTCCTTG-3V/5V-GGTACAGTTGTTTTTCCCCTTTT-
3V, and pair 2, 5V-AACTCTAGCCAATTGCACCACC-3V/5V-GGCCATACTT-
CAGAAGCTGCA-3V. The point at which the amplification plot crossed the
threshold was defined as Ct, which represented the cycle number at this point.
The Ct values of transcripts of the distal promoter were determined directly from
primer pair 1-derived PCR product. Ct values originating only from the
proximal promoter had to be determined indirectly by subtraction of the copy
number yielded from primer pair 1 from the copy number yielded from primer
pair 2. In all TaqMan assays the transcript levels of the housekeeping proteins
clathrin (primer pair 3, 5V-ACAGAGACACAGCCCATTGTT-3V/5V-CCCA-
TACGGTGGTGCAGTAT-3V) and h2-microglobulin (primer pair 4, 5V-
GCTATCCGAAACCCCTCAAA-3V/5V-GGCGGGTGGAACTGTGTTA-3V)
were determined and used to normalize data of each tissue between mouse
individuals. C t values were normalized to the Ct values of the controls and given
as DCt (DCt = Ct  (Ct h2-microglobulin + Ctclathrin)/2).
Generation and luciferase activity assay of Gpr34-promoter
constructs
To analyze functionally potential promoter sequences of mGpr34, firefly
luciferase was amplified from the pUHC-13-3 vector (BD Biosciences) and
cloned into the pcDNAI-Amp vector (referred to as Luc-pcDNAI/Amp). To
ensure an equal sequence context of the mRNA upstream of the putative
translational start, the entire 5V UTR sequence of the murine mRNA, including
positions 1 to 95, exon 2 (5673 to 5739), and exon 1 (6347 to 6355)
(see Fig. 1), was amplified from cDNA prepared from the murine macrophage
cell line RAW 264.7 and inserted 5V of the start ATG of luciferase (referred to as
no-Pro; see Fig. 4). To test whether intron 1 (located between exons 1 and 2, Fig.
1A) of mGPR34 has an influence on promoter activity, the sequence of intron 1
was inserted between exon 1 and exon 2 (Fig. 4, referred to as no-Pro-Int). On the
basis of these two constructs (no-Pro and no-Pro-Int) 0.5 kb (positions6359 to
6821), 1.5 kb (positions 6359 to 7816), and 2.0 kb (positions 6359 to
8289) of the putative promoter sequence were inserted upstream of the 5VUTR
sequence (see Fig. 4). For control purposes, the CMV promoter sequence was
inserted into both basic constructs, yielding constructs CMV and CMV-Int (see
Fig. 4).
To verify the results with pcDNAI-Amp vector constructs, the pGL3 vector
(Promega, Mannheim, Germany) was used as plasmid backbone. Here, the
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promoter regions (0.5, 1.5, 2.0 kb) and the start ATG of luciferase (see Fig. 4).
Basal luciferase activity was determined with a construct not containing the
putative promoter regions and a construct containing the SV40 promoter served
as positive control. The sequence of all constructs was verified by restriction
analysis and sequencing of PCR-derived fragments.
The luciferase activity assay was performed with a luciferase activity
detection system based on the method described in van Leeuwen et al. [26].
Briefly, COS-7 cells and RAW 264.7 cells were grown in Dulbecco’s modified
Eagle’smedium supplementedwith 10% fetal bovine serum, 100U/ml penicillin,
and 100 Ag/ml streptomycin at 37-C in a humidified 7% CO2 incubator. COS-7
cells were seeded in 12-well plates (180,000 cells per well) and transfected with 5
Ag of plasmidDNA per well by a Ca2+-coprecipitationmethod [27]. Transfection
of RAW cells was performed with 5 Al of Rotifectene (Roth, Karlsruhe,
Germany) and 1 Ag of plasmid DNA per well in a 12-well plate. Medium was
changed 3 h later and 2 days after transfection cells were washed with PBS. Cell
lysis was induced by adding 100 Al of lysis buffer (77 mM K2HPO4, 23 mM
KH2PO4, 0.2% Triton X-100, 1 mM DTT, pH 5.8). Twenty microliters of lysate
wasmixedwith 100 Al of luciferase buffer (20mMTricine, 2.67mMMgSO4, 0.1
mM EDTA, 33.3 mM DTT, 270 AM coenzyme A, 530 AM ATP, 470 AM d-
luciferin) and luminescence was measured for 1 s in the Victor 2-1420Multilabel
counter (Wallac–Perkin Elmer LAS, Ju¨ngesheim, Germany).
Analysis of translational start points in human GPR34
To identify the translation initiation codon(s) a combinatory mutagenesis
strategy of the first three in-frame AUG codons of hGPR34 was performed.
Translation was monitored by measurement of the fluorescence emitted by
GPR34–GFP fusion constructs generated by fusing the coding sequence of
GFP (without the translation initiation AUG) to the C terminus of hGPR34
without the endogenous stop codon by an overlap PCR strategy. To simulate
the natural sequence environment in the pcDps expression vector [28], a 108-bp
fragment of the hGPR34 5V UTR region (positions 108 to 1) was inserted
directly upstream of the first in-frame AUG. The first three in-frame AUG
codons were next combinatorially changed by mutating AUG to UUG
(construct series A, Fig. 5B).
In the second set of constructs (construct series B, Fig. 5C), only the coding
region of the N terminus was fused to GFP, and AUG codons were mutated. For
control purposes an out-of-frame AUG codon located at position +125 in the
coding region was set in-frame to GFP.
The last constructs (construct series C, Fig. 5D) were further shortened,
such that only codons 1 to 15 were maintained, and fused to GFP and contained
only the first and the second in-frame AUG. The identities of the various
constructs and the correctness of all PCR-derived sequences were confirmed by
restriction analysis and sequencing.
Immunofluorescence studies were carried out to examine the subcellular
distribution of the different AUG-GPR34/GFP chimeras. COS-7 cells were
seeded into six-well plates containing sterilized glass coverslips and transfected
as described above. Approximately 48 h later, cells were fixed and fluorescence
images were obtained with a confocal laser-scanning microscope (LSM 510;
Carl Zeiss Jena, Jena, Germany).
For quantification of GFP expression, COS-7 cells were seeded and
transfected as described for the luciferase assay (see above). Two days after
transfection cells were washed three times with PBS and then detached by
adding 450 Al of 5 mM EDTA in PBS. Measurement of GFP fluorescence was
performed with 200-Al samples in the Victor 2-1420 multilabel counter
(Wallac) for 0.1 s, using a 460 nm excitation filter and 525 nm emission filter.
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